CRBU
Price
$1.79
Change
-$0.01 (-0.56%)
Updated
Sep 17, 12:15 PM (EDT)
Capitalization
170.42M
55 days until earnings call
FULC
Price
$7.30
Change
-$0.00 (-0.00%)
Updated
Sep 17, 12:22 PM (EDT)
Capitalization
382.43M
56 days until earnings call
Interact to see
Advertisement

CRBU vs FULC

Header iconCRBU vs FULC Comparison
Open Charts CRBU vs FULCBanner chart's image
Caribou Biosciences
Price$1.79
Change-$0.01 (-0.56%)
Volume$181
Capitalization170.42M
Fulcrum Therapeutics
Price$7.30
Change-$0.00 (-0.00%)
Volume$100
Capitalization382.43M
CRBU vs FULC Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. FULC commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FULC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (CRBU: $1.80 vs. FULC: $7.30)
Brand notoriety: CRBU and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 87% vs. FULC: 58%
Market capitalization -- CRBU: $170.42M vs. FULC: $382.43M
CRBU [@Biotechnology] is valued at $170.42M. FULC’s [@Biotechnology] market capitalization is $382.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and FULC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 2 TA indicator(s) are bullish while FULC’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 2 bullish, 5 bearish.
  • FULC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FULC is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -2.17% price change this week, while FULC (@Biotechnology) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +6.98%, and the average quarterly price growth was +35.80%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

FULC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($382M) has a higher market cap than CRBU($170M). FULC YTD gains are higher at: 55.319 vs. CRBU (13.208). FULC has higher annual earnings (EBITDA): -81.28M vs. CRBU (-150.76M). FULC has more cash in the bank: 214M vs. CRBU (184M). FULC has less debt than CRBU: FULC (7.57M) vs CRBU (25.9M). CRBU has higher revenues than FULC: CRBU (9.12M) vs FULC (0).
CRBUFULCCRBU / FULC
Capitalization170M382M45%
EBITDA-150.76M-81.28M185%
Gain YTD13.20855.31924%
P/E RatioN/AN/A-
Revenue9.12M0-
Total Cash184M214M86%
Total Debt25.9M7.57M342%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFULC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 20 days ago
88%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGMGF0.280.08
+39.15%
Theta Gold Mines Limited
CURLF2.540.18
+7.80%
Curaleaf Hldgs Inc.
NNUP1.50N/A
N/A
Nocopi Technologies, Inc.
KIGRY16.68-0.13
-0.77%
KION GROUP AG
LRLCY89.26-2.06
-2.26%
L'Oreal Co.

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-1.64%
CRSP - CRBU
59%
Loosely correlated
+5.79%
BEAM - CRBU
54%
Loosely correlated
+7.66%
FATE - CRBU
53%
Loosely correlated
-0.53%
RXRX - CRBU
52%
Loosely correlated
+1.47%
MGNX - CRBU
52%
Loosely correlated
-5.77%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+3.25%
SLS - FULC
48%
Loosely correlated
-0.60%
ANNX - FULC
40%
Loosely correlated
+6.43%
VRDN - FULC
39%
Loosely correlated
+3.61%
MRNA - FULC
38%
Loosely correlated
+4.02%
MLTX - FULC
34%
Loosely correlated
-0.02%
More